Cleared Special

K212725 - ViperCross Support Catheters

K212725 is the FDA 510(k) clearance for ViperCross Support Catheters by Cardiovascular Systems, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 28-day FDA review.

K212725 · Cardiovascular Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
28d
Days
Class 2
Risk

K212725 is an FDA 510(k) clearance for the ViperCross Support Catheters. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cardiovascular Systems, Inc. (St.Paul, US). The FDA issued a Cleared decision on September 24, 2021 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cardiovascular Systems, Inc. devices

Submission Details

510(k) Number K212725 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2021
Decision Date September 24, 2021
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Biomerics
Jonathan Holmes

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQY Catheter, Percutaneous

All 576
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K212725.
XO Cross Support Catheter
K210322 · Transit Scientific, LLC · Oct 2021
Amplatzer Steerable Delivery Sheath
K212026 · Abbott Medical · Sep 2021
Amplatzer Talisman Delivery Sheath
K212738 · Abbott Medical · Sep 2021
ViperCross Support Catheters
K211240 · Cardiovascular Systems, Inc. · Aug 2021
WATCHMAN FXD Curve Access System
K212228 · Boston Scientific Corporation · Aug 2021
Rist 071 Radial Access Guide Catheter
K211990 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Jul 2021